DPharm 2022: Disruptive Innovations US

Book a meeting

Real world data has become a critical part of evidence generation for clinical programs, supporting not only post-approval activities but increasingly vital for approval-related regulatory filings as well.​

Both the patient and site experiences for trial related activities are key to accelerating recruitment, maintaining engagement and reducing patient attrition during a study.​

Evidence and treatment plans that focus solely on one aspect of the patient’s healthcare journey is insufficient for success within an increasingly competitive market—instead, therapeutics that take into account the entire patient journey—before diagnosis, during the initial phases of treatment and beyond, are best positioned for optimal patient, and financial, outcomes.​

The Syneos Health End-to-End Patient Journey capability provides the ability to fully understand the patient and their healthcare journey before, during and after a clinical study. 

Meet with us at DPharm to discuss how integrating an understanding of a true patient journey - the unique patient-focused drivers of efficacy, adherence and safety - can be developed to improve both direct health outcomes and overall quality of life. ​​

Book a meeting

Find us at Booth #52!

Keynote Presentation | September 13 | 12 PM 

End-to-End Digital Patient Journey: Insight Into Patients Before, During and After a Clinical Trial Through Tokenization

Want to learn more? Access our full website here, explore Insights Hub for the latest industry perspectives, subscribe to our podcast, or click on the resources below:

Enhancing Patient Acceptance of Biosimilars

The Promise and Potential of Digital Mental Health Solutions

Designing Gene Therapy Study Protocols Based on Patient Burden Scores